Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. financial statements

Gyre Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 116.59M10-K
Net incomeUSD 9.88M10-K
Cash and equivalentsUSD 49.19M10-Q

Gyre Therapeutics, Inc. financials on 6ix · Gyre Therapeutics, Inc. on 6ix